The FDA approved the Covid-19 for children 28 days of age and older and weighing more than 6.6 pounds in order to protect them from the omicron variant of the remdesivir that has caused a spike in hospitalizations.
There is a small amount of the Covid-19 antiviral remdesivir.
The first FDA-approved Covid-19 treatment for children under 12 is marketed under the brand name Veklury.
Children under 12 years old can only use Covid-19 treatments if there is a public health emergency.
The FDA said clinical trials on Covid-19 patients as young as 28 days of age showed the same effects on young children as on adults.
The FDA said that remdesivir does not serve as a vaccine substitute for patients who can't safely receive vaccines.
Patients with the disease are more likely to experience mild side effects like nausea than patients without the disease.
Monday was the last time remdesivir was approved for people over the age of 12.
One of the first treatments approved for use on hospitalized Covid-19 patients was remdesivir. The World Health Organization issued a recommendation against using the drug after conflicting results on its usefulness were produced. A patient who had previously received the drug was found to have a remdesivir-resistant strain of the coronaviruses. Since the emergence of the omicron variant, there has been a need to expand access to Covid-19 treatments for people under 5 years old. Omicron has caused a fourfold increase in Covid-19 hospitalizations among children.
In a once-per-day session lasting between 30 minutes and two hours, Remdesivir is given in a once-per-day session.
The Challenges of Treating Covid-19: Lessons from Gilead.
All Rights Reserved © 2024
